Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $180.90M.
ENTERPRISE VALUE (EV)
$180.90M
RxSight, Inc.
Market Cap
$190.97M
Enterprise Value (EV)
$180.90M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| RxSight, Inc. (RXST) | $190.97M | $180.90M |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $191.14M | $204.04M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $186.79M | $180.46M |
| AN2 Therapeutics, Inc. (ANTX)vs › | $185.12M | $140.81M |
| Alector, Inc. (ALEC)vs › | $198.73M | $171.58M |
| Canton Strategic Holdings Inc (CNTN)vs › | $182.39M | $145.15M |
| Exagen Inc. (XGN)vs › | $199.92M | $200.88M |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $200.68M | $116.92M |
| Compass Therapeutics, Inc. (CMPX)vs › | $180.99M | $155.17M |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.31M | $165.80M |
Market Cap
$190.97M
Total Debt
$9.88M
Cash
$19.95M
Enterprise Value
$180.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
